UK markets closed

BiVictriX Therapeutics Plc (BVX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
11.000.00 (0.00%)
At close: 02:04PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,952
2,110
711
306
-
Selling general and administrative
754
738
567
211
-
Total operating expenses
2,815
2,975
1,502
521
526
Operating income or loss
-2,815
-2,975
-1,502
-521
-526
Interest expense
-
-
641
19
-
Income before tax
-2,811
-2,971
-2,532
-509
-526
Income tax expense
-483
-474
-192
-84
-117
Income from continuing operations
-2,328
-2,497
-2,340
-425
-409
Net income
-2,328
-2,497
-2,340
-425
-409
Net income available to common shareholders
-2,328
-2,497
-2,340
-425
-409
Basic EPS
-0.04
-0.04
-0.06
-0.01
-0.01
Diluted EPS
-0.04
-0.04
-0.06
-0.01
-0.01
Basic average shares
66,115
66,115
38,866
66,115
66,115
Diluted average shares
66,115
66,115
38,866
66,115
66,115